NFKB1 and B-cell chronic lymphocytic leukemia: Here we demonstrated that, in the CLL-derived B cell line MEC-1, the exogenous administration of ROS suppresses the transcriptional activity of the p65 subunit of NF-κB in a dose-dependent manner, suggesting that redox signaling negatively controls NF-κB activation in these cells.